DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) - TRILLIUM THERAPEUTICS INC ownership

TRILLIUM THERAPEUTICS INC's ticker is and the CUSIP is 89620X506. A total of 33 filers reported holding TRILLIUM THERAPEUTICS INC in Q3 2015. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) ownership history of TRILLIUM THERAPEUTICS INC
ValueSharesWeighting
Q3 2016$2,547,000
+64.6%
172,3070.0%0.12%
+93.4%
Q2 2016$1,547,000
-2.9%
172,3070.0%0.06%
-10.3%
Q1 2016$1,594,000
-26.6%
172,3070.0%0.07%
-22.7%
Q4 2015$2,173,000
-3.2%
172,3070.0%0.09%
+1.1%
Q3 2015$2,245,000
-40.3%
172,3070.0%0.09%
-30.4%
Q2 2015$3,760,000
-17.8%
172,307
-23.8%
0.12%
-15.5%
Q1 2015$4,573,000226,0640.15%
Other shareholders
TRILLIUM THERAPEUTICS INC shareholders Q3 2015
NameSharesValueWeighting ↓
NEA Management Company, LLC 2,100,000$646,0000.05%
Matrix Capital Management Company, LP 2,288,560$704,0000.02%
Tekla Capital Management LLC 446,099$137,0000.01%
Realta Investment Advisors 26,000$7,0000.00%
Virtu Financial LLC 34,991$11,0000.00%
Baker Brothers Advisors 505,262$155,0000.00%
BOOTHBAY FUND MANAGEMENT, LLC 20,044$6,0000.00%
MORGAN STANLEY 1,160,098$356,0000.00%
BANK OF MONTREAL /CAN/ 18,333$6,0000.00%
GEODE CAPITAL MANAGEMENT, LLC 102,725$31,0000.00%
View complete list of TRILLIUM THERAPEUTICS INC shareholders